Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Cardiac Surgery Patients: Protocol Update for an Ongoing Phase 3, Double-Blind, Placebo-Controlled, Multicenter Study
Publication
, Conference
Levy, JH; Argyle, C; Solomon, C; Knaub, S
Published in: Blood
November 5, 2024
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
4026.1 / 4026.1
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Levy, J. H., Argyle, C., Solomon, C., & Knaub, S. (2024). Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Cardiac Surgery Patients: Protocol Update for an Ongoing Phase 3, Double-Blind, Placebo-Controlled, Multicenter Study. In Blood (Vol. 144, pp. 4026.1-4026.1). American Society of Hematology. https://doi.org/10.1182/blood-2024-205111
Levy, Jerrold H., Catrin Argyle, Cristina Solomon, and Sigurd Knaub. “Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Cardiac Surgery Patients: Protocol Update for an Ongoing Phase 3, Double-Blind, Placebo-Controlled, Multicenter Study.” In Blood, 144:4026.1-4026.1. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-205111.
Levy JH, Argyle C, Solomon C, Knaub S. Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Cardiac Surgery Patients: Protocol Update for an Ongoing Phase 3, Double-Blind, Placebo-Controlled, Multicenter Study. In: Blood. American Society of Hematology; 2024. p. 4026.1-4026.1.
Levy, Jerrold H., et al. “Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Cardiac Surgery Patients: Protocol Update for an Ongoing Phase 3, Double-Blind, Placebo-Controlled, Multicenter Study.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 4026.1-4026.1. Crossref, doi:10.1182/blood-2024-205111.
Levy JH, Argyle C, Solomon C, Knaub S. Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Cardiac Surgery Patients: Protocol Update for an Ongoing Phase 3, Double-Blind, Placebo-Controlled, Multicenter Study. Blood. American Society of Hematology; 2024. p. 4026.1-4026.1.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
4026.1 / 4026.1
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology